Frederic Sedel, MD
Medday Pharmaceuticals
1
0
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Alain CREANGE, MD
Hôpital Henri Mondor, Créteil, France
Shared therapeutic areas:
Worked with same sponsors:
Tanya J Lehky, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Shared therapeutic areas:
Kuang-Yi Wen, PhD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Shared therapeutic areas:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Bruce Berger, MD
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Shared therapeutic areas:
Ingmar Schäfer, PD Dr.
Universitätsklinikum Hamburg-Eppendorf
Shared therapeutic areas:
Emily Rosario, PhD
Casa Colina Hospital and Centers for Healthcare
Shared therapeutic areas:
Rodica Pop-Busui, MD, PhD
University of Michigan
Shared therapeutic areas:
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Helena Burger, MD, PhD
University Rehabilitation Institute, Republic of Slovenia
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study
All 1 trials loaded